We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$47.3M
(+36%)
Cap. Flow
-$45.9M
Cap. Flow
% of AUM
-25.57%
Top 10 Holdings %
Top 10 Hldgs %
70.76%
Holding
129
New
37
Increased
17
Reduced
26
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$4.98M |
| 2 |
Amgen
AMGN
|
+$2.4M |
| 3 |
Booking.com
BKNG
|
+$2.14M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$2.13M |
| 5 |
NNDM
Nano Dimension
NNDM
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$2.81M |
| 2 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.32M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.44M |
| 4 |
Calix
CALX
|
+$1.11M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.5% |
| 2 | Technology | 5.71% |
| 3 | Consumer Discretionary | 1.17% |
| 4 | Industrials | 1.07% |
| 5 | Energy | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$29.9B
| $3.73M | 2.08% |
+15,800
| New | +$4.98M |
|
|
2
BioMarin Pharmaceuticals
BMRN
$11.5B
| $2.97M | 1.65% |
33,400
+23,000
| +221% | +$2.13M |
|
|
3
Amgen
AMGN
$203B
| $2.38M | 1.33% |
+12,548
| New | +$2.4M |
|
|
4
Booking.com
BKNG
$138B
| $2.09M | 1.17% |
+30,000
| New | +$2.14M |
|
|
AVID
5
DELISTED
Avid Technology Inc
AVID
| $1.89M | 1.05% |
+253,487
| New | +$1.32M |
|
|
6
iShares Russell 2000 ETF
IWM
$80.9B
| $1.75M | 0.97% |
11,414
-9,595
| -46% | -$1.44M |
|
7
American Superconductor
AMSC
$1.48B
| $1.34M | 0.75% |
104,307
-63,693
| -38% | -$866K |
|
8
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $1.34M | 0.75% |
14,612
-1,531
| -9% | -$138K |
|
9
Silicom
SILC
$228M
| $1.2M | 0.67% |
+31,335
| New | +$1.14M |
|
|
10
PUT
Biogen
BIIB
$29.9B
| $1.18M | 0.66% |
+15,800
| New | +$4.98M |
|
11
Airgain
AIRG
$74.3M
| $1.1M | 0.62% |
86,119
-58,992
| -41% | -$692K |
|
|
MDCO
12
PUT
DELISTED
Medicines Co
MDCO
| $1.03M | 0.57% |
150,616
-67,584
| -31% | -$1.59M |
|
13
Pixelworks
PXLW
$38.8M
| $904K | 0.5% |
19,219
+2,398
| +14% | +$106K |
|
14
Digital Turbine
APPS
$1.02B
| $883K | 0.49% |
252,373
-118,206
| -32% | -$324K |
|
|
15
Qualcomm
QCOM
$176B
| $876K | 0.49% |
15,355
-52,089
| -77% | -$2.81M |
|
16
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
| $843K | 0.47% |
14,810
-4,732
| -24% | -$257K |
|
17
Knowles
KN
$3.22B
| $841K | 0.47% |
47,697
+14,859
| +45% | +$230K |
|
18
Allot
ALLT
$374M
| $733K | 0.41% |
92,283
+27,908
| +43% | +$201K |
|
|
XLNX
19
CALL
DELISTED
Xilinx Inc
XLNX
| $722K | 0.4% |
+42,500
| New | +$4.77M |
|
20
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $705K | 0.39% |
7,793
-201
| -3% | -$17.1K |
|
|
DSPG
21
DELISTED
DSP Group Inc
DSPG
| $671K | 0.37% |
47,697
+16,308
| +52% | +$212K |
|
22
Vuzix
VUZI
$190M
| $669K | 0.37% |
218,600
+18,600
| +9% | +$74.6K |
|
23
Clearfield
CLFD
$421M
| $654K | 0.36% |
44,498
+2,851
| +7% | +$37.7K |
|
|
PGNX
24
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $641K | 0.36% |
138,357
+62,157
| +82% | +$281K |
|
25
Transocean
RIG
$5.92B
| $635K | 0.35% |
+73,000
| New | +$625K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Worth Venture Partners held 129 positions worth $180M, up 36% from $132M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Worth Venture Partners withdrew a net $45.9M in Q1 2019, closing 31 positions and reducing 26 holdings. Its most notable exit was State Street SPDR Portfolio Short Term Corporate Bond ETF, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, up from 3.7% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Worth Venture Partners opened a new position in Biogen worth $3.73M.
- Worth Venture Partners's largest Q1 2019 buy was Biogen: 15,800 shares worth $3.73M.
- Worth Venture Partners added most to BioMarin Pharmaceuticals in Q1 2019, an estimated $2.13M increase.
- Worth Venture Partners's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $2.81M.
- Worth Venture Partners fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q1 2019, selling an estimated $2.32M.
- Worth Venture Partners's ten largest holdings make up 71% of its $180M portfolio in Q1 2019.
- Worth Venture Partners opened 37 new positions and closed 31 in Q1 2019.
- Worth Venture Partners's portfolio value rose 36% quarter-over-quarter to $180M.
Based on Worth Venture Partners's 13F filing for Q1 2019, filed 15 May 2019.